Joseph H. Antin

49.6k total citations · 8 hit papers
491 papers, 28.0k citations indexed

About

Joseph H. Antin is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Joseph H. Antin has authored 491 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 378 papers in Hematology, 144 papers in Immunology and 129 papers in Oncology. Recurrent topics in Joseph H. Antin's work include Hematopoietic Stem Cell Transplantation (332 papers), Acute Myeloid Leukemia Research (99 papers) and Immune Cell Function and Interaction (75 papers). Joseph H. Antin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (332 papers), Acute Myeloid Leukemia Research (99 papers) and Immune Cell Function and Interaction (75 papers). Joseph H. Antin collaborates with scholars based in United States, Canada and United Kingdom. Joseph H. Antin's co-authors include Robert J. Soiffer, Corey Cutler, Edwin P. Alyea, Vincent T. Ho, Haesook T. Kim, Jerome Ritz, John Koreth, Stephanie J. Lee, Philippe Armand and David Porter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Joseph H. Antin

473 papers receiving 27.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

1997 993 citations Joseph H. Antin et al. Journal of Clinical Oncology profile →
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

2011 809 citations John Koreth, Haesook T. Kim et al. profile →
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

2014 611 citations Philippe Armand, Haesook T. Kim et al. Blood profile →
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

2009 604 citations John Koreth, Joseph H. Antin et al. profile →
Clinical and Metabolic Efficacy of Glutamine-supplemented Parenteral Nutrition after Bone Marrow Transplantation

1992 546 citations Joseph H. Antin et al. profile →
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

2001 522 citations Joseph H. Antin et al. Blood profile →
Cholecystokinin elicits the complete behavioral sequence of satiety in rats.

1975 518 citations Joseph H. Antin et al. profile →
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

2017 473 citations Stephanie J. Lee, Corey Cutler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph H. Antin United States	90	17.8k	9.5k	6.4k	4.2k	3.8k	491	28.0k
Claudio Anasetti United States	89	20.3k 1.1×	11.9k 1.3×	5.5k 0.9×	4.7k 1.1×	3.6k 0.9×	459	27.7k
Sergio Giralt United States	86	21.4k 1.2×	7.0k 0.7×	10.0k 1.6×	4.9k 1.2×	5.0k 1.3×	856	30.2k
Jakob Passweg Switzerland	72	13.3k 0.7×	4.7k 0.5×	6.1k 1.0×	2.7k 0.6×	5.5k 1.4×	497	21.0k
Dietger Niederwieser Germany	73	18.3k 1.0×	6.1k 0.6×	5.4k 0.9×	4.5k 1.1×	7.5k 2.0×	535	26.8k
Robert Peter Gale United States	78	14.5k 0.8×	5.3k 0.6×	5.6k 0.9×	3.9k 0.9×	5.6k 1.4×	609	24.0k
Gerhard Ehninger Germany	78	13.6k 0.8×	4.3k 0.5×	6.5k 1.0×	3.8k 0.9×	5.2k 1.4×	678	25.0k
Franco Locatelli Italy	88	12.5k 0.7×	9.9k 1.0×	8.4k 1.3×	3.7k 0.9×	8.1k 2.1×	1.0k	33.0k
Stella M. Davies United States	64	8.7k 0.5×	5.0k 0.5×	3.6k 0.6×	4.3k 1.0×	2.1k 0.5×	518	18.0k
Juliet N. Barker United States	85	8.4k 0.5×	17.3k 1.8×	5.1k 0.8×	1.8k 0.4×	3.2k 0.8×	559	31.3k
Stephen J. Forman United States	100	12.3k 0.7×	9.1k 1.0×	16.3k 2.6×	4.8k 1.1×	4.5k 1.2×	861	36.2k

Countries citing papers authored by Joseph H. Antin

Since Specialization

Citations

This map shows the geographic impact of Joseph H. Antin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Antin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Antin more than expected).

Fields of papers citing papers by Joseph H. Antin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Antin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Antin. The network helps show where Joseph H. Antin may publish in the future.

Co-authorship network of co-authors of Joseph H. Antin

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Antin. A scholar is included among the top collaborators of Joseph H. Antin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Antin. Joseph H. Antin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Haesook T., Vincent T. Ho, Sarah Nikiforow, et al.. (2024). Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis. Transplantation and Cellular Therapy. 30(7). 687.e1–687.e13. 3 indexed citations

Iftikhar, Raheel, Amy E. DeZern, Michael A. Pulsipher, et al.. (2024). Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy. Transplantation and Cellular Therapy. 30(12). 1155–1170. 5 indexed citations

Gupta, Neha, César A. Virgen, Amrita Goyal, et al.. (2023). Novel use of acitretin for posttransplant Grover’s disease and cutaneous graft versus host disease. JAAD Case Reports. 33. 67–69.

Maurer, Katie, Vincent T. Ho, Corey Cutler, et al.. (2023). Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD. Blood Advances. 7(15). 3903–3915. 14 indexed citations

Maurer, Katie, Haesook T. Kim, Deborah Liney, et al.. (2023). Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells. Blood Advances. 7(11). 2431–2435. 7 indexed citations

Johnson, P. Connor, Haesook T. Kim, Meghan E. Sise, et al.. (2023). Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(7). 455.e1–455.e9. 3 indexed citations

Fuchs, Ephraim J., Paul V. O’Donnell, Mary Eapen, et al.. (2020). Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137(3). 420–428. 106 indexed citations

Kim, Haesook T., Lindsey E. Roeker, Corey Cutler, et al.. (2019). Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). 529–539. 16 indexed citations

Kekre, Natasha & Joseph H. Antin. (2016). Emerging drugs for graft-versus-host disease. Expert Opinion on Emerging Drugs. 21(2). 209–218. 6 indexed citations

10.

Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations

11.

Leen, Ann M., Catherine M. Bollard, Adam Mendizabal, et al.. (2013). Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 121(26). 5113–5123. 392 indexed citations

12.

Koreth, John, Kristen E. Stevenson, Haesook T. Kim, et al.. (2012). Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology. 30(26). 3202–3208. 104 indexed citations

13.

Weigert, Oliver, Nadja Kopp, Andrew A. Lane, et al.. (2011). Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation. Cancer Discovery. 2(1). 47–55. 64 indexed citations

14.

Cutler, Corey, Haesook T. Kim, Gary Bradwin, et al.. (2010). Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury. Biology of Blood and Marrow Transplantation. 16(8). 1180–1185. 60 indexed citations

15.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology. 26(35). 5767–5774. 80 indexed citations

16.

DeMarinis, Valerie, Arthur J. Barsky, Joseph H. Antin, & Grace Chang. (2008). Health psychology and distress after haematopoietic stem cell transplantation. European Journal of Cancer Care. 18(1). 57–63. 16 indexed citations

17.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2007). Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 109(10). 4586–4588. 318 indexed citations

18.

Miklos, David B., Haesook T. Kim, Katherine H. Miller, et al.. (2004). Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 105(7). 2973–2978. 301 indexed citations

19.

Cutler, Corey, et al.. (2000). Incidence of acute and chronic GVHD after allogeneic peripheral blood stem cell and bone marrow transplantation: A meta-analysis. Blood. 96. 2 indexed citations

20.

Chang, Grace, C McGarigle, Thomas R. Spitzer, et al.. (1998). A Comparison of Related and Unrelated Marrow Donors. Psychosomatic Medicine. 60(2). 163–167. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact